John Craig Thompson

John Craig Thompson is a declared insider at 4 companies; the most frequent names are Tetraphase Pharmaceuticals Inc, Anthera Pharmaceuticals Inc and Esperion Therapeutics, Inc. In total, 20 filings cover trades dated from 22 August 2011 to 13 July 2026.

Market trades split into 3 purchases (€22k) and 7 sales (€3.5M). Taken together, the sales exceed the purchases by €3.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 7 option exercises.

In size, the median ticket on the buying side is €9,506.

The latest filing, published on 13 July 2026, reports a transaction in Esperion Therapeutics, Inc. The latest purchase dates back some time: it was published 3,320 days ago, on 20 September 2017. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.